Abstract
Background
To evaluate a new organisational model, “process management” (PM), implemented in the Hospital Universitario Virgen de la Victoria (HUVV) compared with traditional models used in other Radiation Oncology Departments (RODs), in terms of efficacy and efficiency.
Methods
The study period ranged from September 2011 to August 2012. Efficacy was assessed, comparing the number of patients attended in first consultation and treated per month, average waiting time from referral to first visit and average waiting time from first visit to treatment. Data were collected from two public hospitals in Andalusia: the HUVV and another Public Hospital in Andalusia (PHA1). Efficiency was assessed comparing the costs per patient attended in first visit and treated at HUVV in 2012 compared with those of a second Public Hospital in Andalusia (PHA2) for 2008. The number of sessions saved using hypofractionation versus classical schemes during the year 2012 in HUVV was estimated, and the money saved was calculated.
Results
In the efficacy analysis, we found significant differences in the average waiting time for first visit, start of treatment, and the number of patients seen and treated annually. After calculating the total cost generated in the ROD, the efficiency analysis showed a lower cost per patient attended in first visit (EUR 599.17) and per patient treated (EUR 783.50), with a saving of 6035 sessions using hypofractionated schemes.
Conclusions
Process management in an ROD reduces time, both to first medical visit and to treatment initiation, allowing an optimisation of linear accelerator (LINAC) capacity.
Similar content being viewed by others
References
Rosenblatt E, Izewska J, Anacak Y, Pynda Y, Scalliet P, Boniol M, et al. RT capacity in European countries: an analysis of the Directory of RT Centres (DIRAC) database. Lancet Oncol. 2013;14(2):e79–86.
Downing A, Gilthorpe MS, Dodwell D, Lawrence G, Forman D. Waiting times for RT after breast-conserving surgery and the association with survival: a path analysis. Clin Oncol (R Coll Radiol). 2011;23(7):442–8.
Kim K, Chie EK, Han W, Noh D-Y, Ha SW. Impact of delayed RT on local control in node-negative breast cancer patients treated with breast-conserving surgery and adjuvant RT without chemotherapy. Tumori. 2011;97(3):341–4.
Wyatt RM, Jones BJ, Dale RG. RT treatment delays and their influence on tumour control achieved by various fractionation schedules. Br J Radiol. 2008;81(967):549–63.
Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, et al. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013;49(7):1627–33.
Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Implications of delayed initiation of RT: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. J Thorac Oncol. 2011;6(11):1857–64.
Rivera C, Mathiaux J, Haaser T, Becqueret H, Jougon J, Trouette R, et al. Delays in the diagnosis and treatment of lung cancer for patients treated with radiation therapy. Bull Cancer. 2012;99(12):1117–22.
Paul C, Carey M, Anderson A, Mackenzie L, Sanson-Fisher R, Courtney R, et al. Cancer patients’ concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journey. Eur J Cancer Care Engl. 2012;21(3):321–9.
Herruzo I, Romero J, Palacios A, Mañas A, Samper P, Bayo E. Libro Blanco SEOR XXI. Análisis de la situación y estrategias de futuro. In Libro blanco de SEOR. 1st ed. Editores Medicos SA (EDIMSA). 2010;53–95.
Peiró M, Barrubés J. New context and old challenges in the healthcare system. Rev Esp Cardiol. 2012;65(7):651–5.
Mannino M, Yarnold JR. Shorter fractionation schedules in breast cancer RT: clinical and economic implications. Eur J Cancer. 2009;45(5):730–1.
Ko EC, Forsythe K, Buckstein M, Kao J, Rosenstein B. Radiobiological rationale and clinical implications of hypofractionated radiation therapy. Cancer Radiother. 2011;15(3):221–9.
Montero A, Sanz X, Herranz R, Cabrera D, Arenas M, Bayo E. Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions). Breast. 2014;23(4):299–309.
Prades J, Algara M, Espinas JA, Farrus B, Arenas M, Reyes V. Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: a mixed-methods study. Radiother Oncol. 2017;123(1):22–8.
Pennings PS, Goodman JM. Toward a workable framework. In: Pennings PS, Goodman JM, editors. New perspectives on organizational effetiveness. San Francisco: Jossey-Bass; 1977. p. 146–84.
Calzas A, García I, Goicoetxea J, Ruir FJ, Moyano A, Pablos A, Perez JM, Rosado M. Programa de Control de Gestión Hospitalaria (COANh). Sevilla: Servicio Andaluz de Salud. Consejería de Salud; 1997.
Ballesta AM, Bedini JL, Gaya J, Mas E, Pascual C, Raventós J. Aproximación al cálculo del coste estándar por determinación: unidades relativas de valor (URV). Todo Hosp. 1994;107:43–50.
Porceddu SV, Rosser B, Burmeister BH, Jones M, Hickey B, Baumann K, et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment-"Hypo Trial". Radiother Oncol. 2007;85(3):456–62.
Rodrigues G, Videtic GMM, Sur R, Bezjak A, Bradley J, Hahn CA, et al. Palliative thoracic RT in lung cancer: an American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol. 2011;1(2):60–71.
Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast RT (START) Trial A of RT hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9(4):331–41.
Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2010;78(1):11–8.
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M, et al. Long-term results of a randomized trial comparing preoperative short-course RT with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–23.
Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, et al. Prospective randomised multicenter trial on single fraction RT (8 Gy × 1) versus multiple fractions (3 Gy × 10) in the treatment of painful bone metastases. Radiother Oncol. 2006;79(3):278–84.
Consejería de Salud. Plan Integral de Oncología 2007-2012. Sevilla: Junta de Andalucía, Consejería de Salud; 2007.
Govijarm R. El desorden sanitario tiene cura. Desde la seguridad del paciente hasta la sostenibilidad del sistema sanitario con la gestión por procesos. 1st ed. Barcelona: Marge Medica Books 2009; 29–53.
Armstrong EG, Barsion SJ. Creating “innovator’s DNA” in health care education. Acad Med. 2013;88(3):343–8.
Scoccianti S, Agresti B, Simontacchi G, Detti B, Cipressi S, Iannalfi A, et al. From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for RT. Tumori. 2012;98(6):728–35.
Palacios Eito A, Espinosa Calvo M, Mañas Rueda A, de Las Heras M. Radiation oncology: future needs and equipment. Current situation in Spain. Clin Transl Oncol. 2008;10(8):478–85.
Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of RT in Spain: a minimal standard of RT resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.
Slotman BJ, Vos PH. Planning of RT capacity and productivity. Radiother Oncol Febrero de. 2013;106(2):266–70.
The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.
Author information
Authors and Affiliations
Contributions
J. A. Medina and Y. Lupiañez-Perez conceived the study and performed the design. P. Pedrosa, M. Lobato, and Y. Lupiañez-Perez gathered the data. Y. Lupiañez-Perez, J. A. Medina, and J. Gomez-Millan participated in the statistical analysis and interpretation. Y. Lupiañez-Perez and J. Gomez-Millan helped to draft the manuscript.
Corresponding authors
Ethics declarations
Availability of data and material
All data generated or analysed during this study are included in this published article.
Conflict of interest
The authors declare that they have no competing interests.
Funding
This study received no funding.
Rights and permissions
About this article
Cite this article
Lupiañez-Perez, Y., Gomez-Millan, J., Lobato, M. et al. Improving efficacy and efficiency through the implementation of a new organisational model in a Radiation Oncology Department. Clin Transl Oncol 19, 1375–1381 (2017). https://doi.org/10.1007/s12094-017-1678-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-017-1678-2